Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer

ClinicalTrials.gov ID: NCT00002760

Public ClinicalTrials.gov record NCT00002760. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 2:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE III TWO-ARM RANDOMIZED STUDY COMPARING ANTIANDROGEN WITHDRAWAL ALONE VERSUS ANTIANDROGEN WITHDRAWAL COMBINED WITH KETOCONAZOLE AND HYDROCORTISON IN PATIENTS WITH ADVANCED PROSTAGE CANCER

Study identification

NCT ID
NCT00002760
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alliance for Clinical Trials in Oncology
Other
Enrollment
260 participants

Conditions and interventions

Interventions

  • Withdrawal of antiandrogen therapy Other
  • ketoconazole Drug
  • therapeutic hydrocortisone Drug

Other · Drug

Eligibility (public fields only)

Age range
Up to 120 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 1996
Primary completion
Feb 29, 2004
Completion
Mar 31, 2009
Last update posted
Jun 27, 2016

1996 – 2009

United States locations

U.S. sites
2
U.S. states
2
U.S. cities
2
Facility City State ZIP Site status
UCSF Cancer Center and Cancer Research Institute San Francisco California 94115-0128
University of Minnesota Cancer Center Minneapolis Minnesota 55455

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002760, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 27, 2016 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002760 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →